Genentech announced the FDA approved the Lucentis 0.3 mg prefilled syringe to treat diabetic retinopathy with or without diabetic macular edema.
The 0.3 mg prefilled syringe is expected to be available in the second quarter of this year, according to a company press release.
The prefilled syringe, made of borosilicate glass and packaged in a single-use sterile, sealed tray, allows physicians to eliminate several steps in preparing and administering Lucentis (ranibizumab). Physicians do not have to draw the medicine from a vial, disinfect the vial or attach a filter needle (Read more...)
Uncategorized